Realheart Reaches New Milestone With the World’s First Four Chamber Artificial Heart
Press Release, 10 January 2023 Scandinavian Real Heart AB, the company developing the world's first four-chamber total artificial heart (TAH), successfully extended the survival of animals implanted with Realheart’s TAH.Since the series of animal trials with the clinical version of the company's TAH began in 2022, Realheart has been able to increase survival time from one to four days. After implantation, the animal was able to stand up and eat. In addition, Scandinavian Real Heart was able to confirm key TAH performance criteria, including: · No haemolysis (damage to red blood